RVMD
HealthcareRevolution Medicines, Inc.
$95.44+0.37 (+0.39%)
Prev Close
$95.07
Open
$96.44
High
$99.09
Low
$95.19
Volume
900.8K
Market Cap
$20.10B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Revolution Medicines, Inc. (RVMD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 44 insider sales totaling $50.83M. The most recent insider transaction was by GOLDSMITH MARK A (director, officer: See Remarks), who sold $7.28M worth of shares on Mar 3, 2026. Revolution Medicines, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $20.10B.
Buys (12M)
0
$0.00
Sells (12M)
44
$50.83M
Net Activity
Net Seller
$50.83M
Active Insiders
6
last 12 mo
RVMD Price Chart
RVMD Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | GOLDSMITH MARK A | director, officer: See Remarks | Sell | 71,900 | $101.24 | $7.28M | 318,869 |
| Jan 23, 2026↗ | Cislini Jeff | officer: General Counsel | Sell | 908 | $115.60 | $105.0K | 46,976 |
| Jan 21, 2026↗ | Cislini Jeff | General Counsel | Sell | 908 | $115.60 | $105.0K | 0 |
| Jan 9, 2026↗ | Anders Jack | officer: Chief Financial Officer | Sell | 10,000 | $98.00 | $980.0K | 108,065 |
| Jan 9, 2026↗ | Horn Margaret A | officer: Chief Operating Officer | Sell | 75,000 | $100.56 | $7.54M | 162,957 |
| Jan 7, 2026↗ | Anders Jack | Chief Financial Officer | Sell | 10,000 | $98.00 | $980.0K | 0 |
| Jan 7, 2026↗ | Horn Margaret A | Chief Operating Officer | Sell | 75,000 | $100.56 | $7.54M | 0 |
| Dec 16, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 3,104 | $77.09 | $239.3K | 0 |
| Dec 16, 2025↗ | Cislini Jeff | General Counsel | Sell | 2,688 | $76.82 | $206.5K | 0 |
| Dec 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 15,394 | $76.82 | $1.18M | 0 |
| Dec 16, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 4,847 | $76.82 | $372.3K | 0 |
| Dec 16, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 5,447 | $76.82 | $418.4K | 0 |
| Nov 25, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 5,418 | $74.00 | $400.9K | 0 |
| Nov 25, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 66,000 | $75.08 | $4.95M | 0 |
| Nov 18, 2025↗ | Cislini Jeff | General Counsel | Sell | 13,388 | $70.14 | $939.0K | 0 |
| Nov 18, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 20,000 | $70.38 | $1.41M | 0 |
| Nov 12, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 20,000 | $65.07 | $1.30M | 0 |
| Nov 11, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 10,000 | $64.00 | $640.0K | 0 |
| Nov 7, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 30,000 | $60.31 | $1.81M | 0 |
| Oct 17, 2025↗ | Cislini Jeff | General Counsel | Sell | 12,000 | $55.00 | $660.0K | 0 |
| Oct 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 20,000 | $52.74 | $1.05M | 0 |
| Oct 13, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 25,000 | $48.54 | $1.21M | 0 |
| Sep 24, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,799 | $44.26 | $79.6K | 0 |
| Sep 16, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 2,320 | $45.83 | $106.3K | 0 |
| Sep 16, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,869 | $45.82 | $85.6K | 0 |
| Sep 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 13,411 | $45.82 | $614.6K | 0 |
| Sep 16, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 4,775 | $45.82 | $218.8K | 0 |
| Sep 16, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 5,367 | $45.82 | $245.9K | 0 |
| Sep 16, 2025↗ | Wei Lin | Chief Medical Officer | Sell | 2,160 | $45.82 | $99.0K | 0 |
| Sep 11, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 125,000 | $44.46 | $5.56M | 0 |
| Sep 2, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 10,000 | $40.10 | $401.0K | 0 |
| Jun 20, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,912 | $39.61 | $75.7K | 0 |
| Jun 16, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 2,170 | $39.83 | $86.4K | 0 |
| Jun 16, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,878 | $39.83 | $74.8K | 0 |
| Jun 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 13,496 | $39.83 | $537.5K | 0 |
| Jun 16, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 3,510 | $39.83 | $139.8K | 0 |
| Jun 16, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 4,289 | $39.83 | $170.8K | 0 |
| Jun 16, 2025↗ | Wei Lin | Chief Medical Officer | Sell | 2,173 | $39.83 | $86.6K | 0 |
| Mar 20, 2025↗ | Cislini Jeff | General Counsel | Sell | 2,041 | $38.71 | $79.0K | 0 |
| Mar 17, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 1,864 | $39.04 | $72.8K | 0 |
| Mar 17, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,458 | $39.04 | $56.9K | 0 |
| Mar 17, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 11,738 | $39.04 | $458.3K | 0 |
| Mar 17, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 3,058 | $39.04 | $119.4K | 0 |
| Mar 17, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 3,294 | $39.04 | $128.6K | 0 |
RVMD Insider Buying Activity
The following table shows recent insider purchases of Revolution Medicines, Inc. (RVMD) stock reported via SEC Form 4 filings.
No insider buying activity found for RVMD in the last 12 months.
RVMD Insider Selling Activity
The following table shows recent insider sales of Revolution Medicines, Inc. (RVMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | GOLDSMITH MARK A | director, officer: See Remarks | Sell | 71,900 | $101.24 | $7.28M | 318,869 |
| Jan 23, 2026↗ | Cislini Jeff | officer: General Counsel | Sell | 908 | $115.60 | $105.0K | 46,976 |
| Jan 21, 2026↗ | Cislini Jeff | General Counsel | Sell | 908 | $115.60 | $105.0K | 0 |
| Jan 9, 2026↗ | Anders Jack | officer: Chief Financial Officer | Sell | 10,000 | $98.00 | $980.0K | 108,065 |
| Jan 9, 2026↗ | Horn Margaret A | officer: Chief Operating Officer | Sell | 75,000 | $100.56 | $7.54M | 162,957 |
| Jan 7, 2026↗ | Anders Jack | Chief Financial Officer | Sell | 10,000 | $98.00 | $980.0K | 0 |
| Jan 7, 2026↗ | Horn Margaret A | Chief Operating Officer | Sell | 75,000 | $100.56 | $7.54M | 0 |
| Dec 16, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 3,104 | $77.09 | $239.3K | 0 |
| Dec 16, 2025↗ | Cislini Jeff | General Counsel | Sell | 2,688 | $76.82 | $206.5K | 0 |
| Dec 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 15,394 | $76.82 | $1.18M | 0 |
| Dec 16, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 4,847 | $76.82 | $372.3K | 0 |
| Dec 16, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 5,447 | $76.82 | $418.4K | 0 |
| Nov 25, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 5,418 | $74.00 | $400.9K | 0 |
| Nov 25, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 66,000 | $75.08 | $4.95M | 0 |
| Nov 18, 2025↗ | Cislini Jeff | General Counsel | Sell | 13,388 | $70.14 | $939.0K | 0 |
| Nov 18, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 20,000 | $70.38 | $1.41M | 0 |
| Nov 12, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 20,000 | $65.07 | $1.30M | 0 |
| Nov 11, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 10,000 | $64.00 | $640.0K | 0 |
| Nov 7, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 30,000 | $60.31 | $1.81M | 0 |
| Oct 17, 2025↗ | Cislini Jeff | General Counsel | Sell | 12,000 | $55.00 | $660.0K | 0 |
| Oct 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 20,000 | $52.74 | $1.05M | 0 |
| Oct 13, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 25,000 | $48.54 | $1.21M | 0 |
| Sep 24, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,799 | $44.26 | $79.6K | 0 |
| Sep 16, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 2,320 | $45.83 | $106.3K | 0 |
| Sep 16, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,869 | $45.82 | $85.6K | 0 |
| Sep 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 13,411 | $45.82 | $614.6K | 0 |
| Sep 16, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 4,775 | $45.82 | $218.8K | 0 |
| Sep 16, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 5,367 | $45.82 | $245.9K | 0 |
| Sep 16, 2025↗ | Wei Lin | Chief Medical Officer | Sell | 2,160 | $45.82 | $99.0K | 0 |
| Sep 11, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 125,000 | $44.46 | $5.56M | 0 |
| Sep 2, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 10,000 | $40.10 | $401.0K | 0 |
| Jun 20, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,912 | $39.61 | $75.7K | 0 |
| Jun 16, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 2,170 | $39.83 | $86.4K | 0 |
| Jun 16, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,878 | $39.83 | $74.8K | 0 |
| Jun 16, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 13,496 | $39.83 | $537.5K | 0 |
| Jun 16, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 3,510 | $39.83 | $139.8K | 0 |
| Jun 16, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 4,289 | $39.83 | $170.8K | 0 |
| Jun 16, 2025↗ | Wei Lin | Chief Medical Officer | Sell | 2,173 | $39.83 | $86.6K | 0 |
| Mar 20, 2025↗ | Cislini Jeff | General Counsel | Sell | 2,041 | $38.71 | $79.0K | 0 |
| Mar 17, 2025↗ | Anders Jack | Chief Financial Officer | Sell | 1,864 | $39.04 | $72.8K | 0 |
| Mar 17, 2025↗ | Cislini Jeff | General Counsel | Sell | 1,458 | $39.04 | $56.9K | 0 |
| Mar 17, 2025↗ | GOLDSMITH MARK A | See Remarks | Sell | 11,738 | $39.04 | $458.3K | 0 |
| Mar 17, 2025↗ | Horn Margaret A | Chief Operating Officer | Sell | 3,058 | $39.04 | $119.4K | 0 |
| Mar 17, 2025↗ | Kelsey Stephen Michael | See Remarks | Sell | 3,294 | $39.04 | $128.6K | 0 |
RVMD Insiders
Similar Stocks to RVMD
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$538.00+0.97%
$21.50B
INCY
Incyte Corporation
$92.25+0.27%
$20.10B
MRNA
Moderna, Inc.
$52.38-1.89%
$19.96B
ROIV
Roivant Sciences Ltd.
$28.14-1.44%
$19.80B